Sleep Apnea News and Research

RSS

People with both sleep apnea and insomnia more likely to have high blood pressure

The likelihood of high blood pressure is clearly higher among people who have both sleep apnea and insomnia. This is shown by a study from the University of Gothenburg.

18 Nov 2025

Exosomes identified as key mediators in obstructive sleep apnea and its comorbidities

Obstructive sleep apnea (OSA), a global public health issue marked by repeated upper airway collapse during sleep, is tied to diverse diseases-from cardiovascular conditions to cancer.

12 Nov 2025

Type 2 diabetes patients face an elevated risk of hearing loss

As the United States observes American Diabetes Month this November, a comprehensive study published in Otolaryngology–Head and Neck Surgery, the peer-reviewed journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation, reveals that individuals with type 2 diabetes face a significantly elevated risk of hearing loss-a complication that often goes unrecognized and unscreened.

10 Nov 2025

One concussion can raise your car crash risk by nearly 50%

Research shows that concussions elevate the risk of motor vehicle crashes, particularly in the weeks following injury, necessitating enhanced safety measures.

10 Nov 2025

Immigrants with health conditions may be denied visas under new Trump administration guidance

Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a Thursday directive from the Trump administration.

6 Nov 2025

How gut microbes shape sleep: New review reveals microbiome clues to insomnia and apnea

A new Brain Medicine review maps how gut microbes influence sleep disorders, from insomnia and sleep apnea to circadian disruption, via bile acids, neurotransmitters, and immune pathways. The findings highlight gut-driven targets for improving sleep quality through diet, probiotics, and microbiome modulation.

5 Nov 2025

GLP-1 drugs calm inflammation beyond diabetes and weight loss

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent mechanisms. It details preclinical and clinical evidence linking GLP-1 receptor activation to cardiovascular, renal, hepatic, neural, and joint anti-inflammatory effects while outlining uncertainties and future research needs.

4 Nov 2025

New review illuminates the intricate connections between gut microbiota and sleep regulation

A comprehensive review published today in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical pathway in understanding and potentially treating sleep disorders.

4 Nov 2025

Heatwaves can significantly worsen obstructive sleep apnea

During heatwaves, there is an increase in the number of people suffering with obstructive sleep apnoea (OSA), according to a major study published today (Wednesday) in the European Respiratory Journal.

29 Oct 2025

New clinical practice guideline provides updated recommendations for treatment of central sleep apnea

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated recommendations for the treatment of central sleep apnea.

27 Oct 2025

Daytime sleepiness in older adults linked to cognitive decline after surgery

People 60 and older who are excessively sleepy during the day may have more problems with memory and thinking after surgery, suggests a study presented at the ANESTHESIOLOGY 2025 annual meeting.

13 Oct 2025

Older non-English speakers face higher delirium risk after surgery

Older patients who primarily speak a language other than English may face a greater risk of developing delirium after surgery in U.S. hospitals, according to new research presented at the ANESTHESIOLOGY 2025 annual meeting. The

12 Oct 2025

New mothers more likely to experience severe pain and sleep problems after C-section

New mothers are more likely to experience severe pain that disrupts sleep and activities of daily living, as well as develop sleep disorders, if they give birth by cesarean delivery (C-section), suggests research presented at the ANESTHESIOLOGY 2025 annual meeting.

12 Oct 2025

Huawei smartwatch nearly matches gold-standard sleep test

A study reveals the HUAWEI WATCH GT2 smartwatch accurately tracks sleep stages, yet it falls short in diagnosing sleep disorders compared to PSG.

7 Oct 2025

Sleep apnea patients in high-pollution areas suffer higher disease severity, study shows

People who have obstructive sleep apnea (OSA) may suffer worse symptoms if they live in areas with higher levels of air pollution, according to a multi-national study presented at the European Respiratory Society (ERS) Congress in Amsterdam, the Netherlands.

29 Sep 2025

Exercise helps improve sleep and mood in smokers over 40

Getting enough weekly exercise may help smokers over 40 reduce depression and sleep issues to levels seen in non-smokers, according to a study from the Texas A&M University School of Public Health.

26 Sep 2025

Orforglipron pill improves heart and metabolic risk factors in trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase 3 clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

22 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.